三维定量结构-活性关系 暂时受体潜力的研究 瓦尼洛伊德1通道对手 揭示了药物设计目的的潜力
Beatrice Gianibbi1, Anna Visibelli1, Giacomo Spinsanti1,2
1Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
International journal of molecular sciences
|July 27, 2024
概括
研究人员改进了针对TRPV1通道的候选药物,以缓解慢性疼痛. 新化合物显示增强的抑制率,表明更好的疼痛管理疗法的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
- 计算化学的计算化学
背景情况:
- 暂时受体潜在化物1 (TRPV1) 是慢性疼痛管理的目标.
- 以前针对TRPV1的候选药物显示出有限的治疗成功.
研究的目的:
- 设计新型TRPV1抑制剂,改善慢性疼痛的疗效.
- 为药物发现利用冷电磁结构和计算建模.
主要方法:
- 虚拟查使用从TRPV1 Cryo-EM结构衍生的药模型.
- 开发和验证3D-QSAR模型与干抑制率相关联.
- 基于现有支架的新化合物的设计和in silico评估.
主要成果:
- 使用TRPV1对抗者-通道复合结构构建了一个药模型.
- 一个经过验证的3D-QSAR模型预测了连接体抑制率.
- 新设计的化合物表现出有希望的抑制率,超过了母化合物.
结论:
- 计算方法,包括药模拟和3D-QSAR,对于优化TRPV1抑制剂是有效的.
- 对TRPV1向化合物的进一步优化对慢性疼痛治疗具有重大潜力.
相关概念视频
Structure-Activity Relationships and Drug Design
689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Voltage-gated Ion Channels
8.1K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.1K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K


